The SITC Forward Fund is pleased to announce the recipients of 2021 SITC Fellowships to support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of impactful research.
The 2021 SITC Fellowships recipients are:
 |
SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship
Recipient: Karlo Perica, MD, PhD
Institution: Memorial Sloan Kettering Cancer Center
Project Title: “Allogeneic CAR T Cell Therapy: Overcoming Host-Versus-Graft Immunity”
Award Amount: $200,000 (two-year)
|
 |
SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship
Recipient: Benjamin Goldenson, MD, PhD
Institution: University of California, San Diego
Project Title: “Chimeric Antigen Receptor Natural Killer Cells for the Treatment of Acute Myeloid Leukemia”
Award Amount: $100,000 (one-year)
|
 |
SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship
Recipient: Biagio Ricciuti, MD
Institution: Dana-Farber Cancer Institute
Project Title: “Dissecting the genomic correlates of response and acquired resistance to PD-(L)1 inhibition in non-small cell lung cancer”
Award Amount: $100,000 (one-year)
|
 |
SITC-Nektar Therapeutics Equity and Inclusion in Cancer Immunotherapy Fellowship
Recipient: Elen Torres, PhD
Institution: Koch Institute for Integrative Cancer Research at MIT
Project Title: “The role of tumor cell-intrinsic Sox2 in the anti-tumor immune response in non-small cell lung cancer (NSCLC)”
Award Amount: $50,000 (one-year)
|
 |
2021 NCI Immunotherapy Fellowship
Recipient: Vincent I. Poon, MD
Institution: BC Cancer Vancouver
Award: Co-Sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and SITC, made possible in part by an educational grant from EMD Serono. This 1-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy. Click here for more information on this fellowship.
|
 |
2021 NCI Immunotherapy Fellowship
Recipient: Nicholas Tschernia, MD
Institution: University of North Carolina at Chapel Hill
Co-Sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and SITC, made possible in part by an educational grant from EMD Serono. This 1-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy.
|
The 2021 SITC Fellowships were made possible through the generosity of Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, EMD Serono and Nektar Therapeutics